Aplastic Anemia ka treatment

| Category | Criteria |
|---|---|
| Severe AA (SAA) | BM cellularity <25% + ≥2 of: ANC <500, Platelets <20,000, Reticulocytes <20,000 |
| Very Severe AA (VSAA) | SAA jaise + ANC <200 |
| Non-Severe AA | Criteria poore nahi hote |
⚠️ Important: Transplant candidates ko family members ka blood bilkul mat chadhaein — HLA sensitization ka risk hota hai.
| Drug | Dose | Role |
|---|---|---|
| Horse ATG (hATG) | 40 mg/kg/day × 4 days | T-cell destruction |
| Cyclosporine (CsA) | 12–15 mg/kg/day divided BD | Immune suppression, relapse prevention |
| Eltrombopag | 150 mg/day | TPO-receptor agonist, ~20% response badhata hai |
| Corticosteroids | Pehle 2 weeks | Serum sickness rokne ke liye |
Horse ATG > Rabbit ATG — Front-line treatment mein horse ATG superior hai.
| Treatment | Outcome |
|---|---|
| IST (hATG + CsA + Eltrombopag) | 70–80% hematologic response; 5-yr survival 60–85% |
| IST long-term | 15-yr overall survival ~60%; failure-free survival <50% |
| Matched sibling HSCT | ~90% survival in children |
| Alternative donor HSCT | Improving outcomes; haploidentical + post-transplant Cy promising |